Because of the unacceptably high rate of adverse patient events, including deaths, linked to the point-of-care (POC) use of glucose meters within hospitals, there is a recognized need for more accuracy and better performance standards for POC glucose testing in hospitals, particularly in intensive care settings.
StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients.
Proven safety and accuracy
Use of any other meter with critically ill patients is considered off label in the U.S. by the FDA and high complexity testing under CLIA
Use of any other glucose meter with critically ill patients is off label
StatStrip is FDA and Health Canada cleared and CLIA waived for use throughout all hospital and all professional healthcare settings including critical care. Use of any other glucose meter with critically ill patients is considered off-label in the U.S. by the FDA and high complexity testing under CLIA.
The personnel testing requirements for off-label use are very demanding and limit who can perform testing. In addition, a hospital must obtain patient consent to perform off-label testing.
The most extensively studied and proven glucose measurement technology
In addition to the studies submitted to the FDA, 168 other independent studies over the last eight years—including 53 critical care studies—have found no clinically significant interferences for StatStrip. This is a statement that no other glucose meter manufacturer can make. Download a bibliography of publications here
For more information click here
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
Cero Generation Launches 70MW Agrivoltaic Project in Italy with Support from Philips & HEINEKEN
Cero Generation’s 70MW agrivoltaic solar PV project in Province of Latina... Read more
Agamon Health Partners with Mayo Clinic to Bridge Cardiology Gaps Using AI Know-How
Agamon Health's Patient Adherence platform is aimed at raising standards... Read more
Hologic & Bayer Partner for Global Enhanced Mammography Solutions to Imaging Centers
Partnership Includes Education and Training to Increase Clinician Confidence... Read more
Breast cancer: more cases detected with the help of AI
One radiologist supported by AI detected more cases of breast cancer... Read more
Championing Billions of Women Through the Hologic Global Women’s Health Index
The invitation proved too momentous to pass up. It arrived as... Read more
JOIN OUR MANAGEMENT COMMUNITY
MediView Announces New Board Member
MediView is pleased to announce the addition of Karley Yoder as a new... Read more
Foldax Appoints Scott Huennekens to Board of Directors
Foldax®, Inc. has announced the appointment of medical device veteran... Read more
Dr Gregor Smith: Scotland’s New Interim CMO
Dr Gregor Smith has been appointed Scotland's interim Chief Medical... Read more
NICE Appoints New CEO
The UK’s National Institute for Health and Care Excellence (NICE)... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
JOIN OUR MANAGEMENT COMMUNITY